Skip to content

The Effect of MDZ on Movement During UIA Clipping

Effects of Midazolam on the Occurrence of Intraoperative Movement in Patients Undergoing Unruptured Intracranial Aneurysm Clipping Surgery: a Prospective Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05553678
Enrollment
64
Registered
2022-09-23
Start date
2022-09-29
Completion date
2023-12-31
Last updated
2022-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Movement

Brief summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.

Interventions

DRUGMidazolam

Midazolam (0.03 mg/kg/30 min) will administered during UIA clipping through microscope.

DRUGNormal saline

Normal saline (0.03 mg/ml/30 min) will administered during UIA clipping through microscope.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who undergo elective unruptured intracranial aneurysm clipping surgery * American Society of Anesthesiologists grade 1,2,3 * age \> 18 year old

Exclusion criteria

* Refuse to participate to the study * Body Mass Index \< 18.5 kg/m2 or \> 35 kg/m2 * Allergic history of benzodiazepine * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative movementDuring microscopic surgeryIncidence

Secondary

MeasureTime frameDescription
Motor evoked potential Latencyimmediately postoperative surgeryLatency
Duration of mechanical ventilation timeEnd of surgery to extubation timeduration
Motor evoked potential amplitudeimmediately postoperative surgeryamplitude
Satisfaction score for intraoperative environmentimmediately postoperative surgeryusing 11-point score (0=worst dissatisfied, 10=very sattisfied)
Postoperative deliriumPostoperative 24 hourIncidence
Duration of ICU stayFrom date of ICU admission until the date of first discharge from ICU, assessed up to 1 weekduration of ICU stay, day

Countries

South Korea

Contacts

Primary ContactChang-Hoon Koo
vollock9@gmail.com+821085098841

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026